Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Cancer Genetics to Evaluate Biomarkers for Effector Therapeutics

Cancer Genetics to Evaluate Biomarkers for Effector Therapeutics

Apr 10, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Cancer Genetics said today that it has been hired by Effector Therapeutics to provide clinical biomarker services for Effector's lead product candidate, eFT508 — a highly selective oral small molecule inhibitor of MNK1 and MNK2.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Mix of Human and Monkey

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

Fetal Tissue Policy Changes Expected

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

Science Papers on Approach to Isolate DNA from Sediment, Algorithm to Construct Signaling Networks

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Sequencing the Zoo

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.

What's Popular?

In Business News

  1. Thermo Fisher Scientific to Acquire Contract Research Organization PPD for $17.4B

  2. People in the News: New Appointments at ACMG, InterVenn Biosciences, Castle Biosciences, More

  3. Cancer Dx Firm C2i Genomics Raises $100M in Financing

  4. Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

  5. French Single-Cell Analysis Startup Minos Biosciences Raises €1.5M

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.